Skip to Content

Suanfarma, Italy, 2026

GMP Audit Report

Company
Suanfarma Italia S.P.A.

Product(s)
Tiamulin hydrogen fumerate 

Country
Italy

Audit Year
2025

0.00 € 0.00 €
0.00 €